Occam Sciences Overview
- Founded
-
2011
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
Occam Sciences General Information
Description
Provider of therapeutic drug development services intended to offer bio-available forms of approved drugs. The company's services include developing drugs using green chemistry to design drugs that are bioavailable, enabling researchers to develop oral drugs.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 33 Whitney Street
- New Haven, CT 06510
- United States
+1 (203) 000-0000
Occam Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 01-Jan-2016 | 00000 | Completed | Startup | ||
| 1. Seed Round | 21-Oct-2011 | 00000 | 00000 | Completed | Startup |
Occam Sciences Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Brian Dixon | Occam Sciences | Board Member | 000 0000 |
| David Whittaker MD | Elm Street Ventures | Board Member | 000 0000 |
| John Warner | Occam Sciences | Board Member | 000 0000 |
| Joseph Pont | Occam Sciences | Board Member | 000 0000 |
| Robert Bettigole | Elm Street Ventures | Board Member | 000 0000 |